202 related articles for article (PubMed ID: 24613524)
1. Impaired serotype-specific immune function following pneumococcal vaccination in infants with prior carriage.
Licciardi PV; Russell FM; Balloch A; Burton RL; Nahm MH; Gilbert G; Tang ML; Mulholland EK
Vaccine; 2014 Apr; 32(20):2321-7. PubMed ID: 24613524
[TBL] [Abstract][Full Text] [Related]
2. The effect of an alternative reduced-dose infant schedule and a second year catch-up schedule with 7-valent pneumococcal conjugate vaccine on pneumococcal carriage: a randomized controlled trial.
Dagan R; Givon-Lavi N; Porat N; Greenberg D
Vaccine; 2012 Jul; 30(34):5132-40. PubMed ID: 22683519
[TBL] [Abstract][Full Text] [Related]
3. Immunogenicity of a 7-valent pneumococcal conjugate vaccine (PCV7) and impact on carriage in Venezuelan children at risk of invasive pneumococcal diseases.
Rivera-Olivero IA; Del Nogal B; Fuentes M; Cortez R; Bogaert D; Hermans PW; Waard JH
Vaccine; 2014 Jun; 32(31):4006-11. PubMed ID: 24837505
[TBL] [Abstract][Full Text] [Related]
4. Pneumococcal conjugate vaccine induced IgG and nasopharyngeal carriage of pneumococci: Hyporesponsiveness and immune correlates of protection for carriage.
Ojal J; Hammitt LL; Gaitho J; Scott JAG; Goldblatt D
Vaccine; 2017 Aug; 35(35 Pt B):4652-4657. PubMed ID: 28739116
[TBL] [Abstract][Full Text] [Related]
5. Lower immunoglobulin G antibody responses to pneumococcal conjugate vaccination at the age of 2 years after previous nasopharyngeal carriage of Streptococcus pneumoniae.
Rodenburg GD; van Gils EJ; Veenhoven RH; Bogaert D; van den Dobbelsteen GP; Berbers GA; Sanders EA
J Pediatr; 2011 Dec; 159(6):965-70.e1. PubMed ID: 21813135
[TBL] [Abstract][Full Text] [Related]
6. No long-term evidence of hyporesponsiveness after use of pneumococcal conjugate vaccine in children previously immunized with pneumococcal polysaccharide vaccine.
Licciardi PV; Toh ZQ; Clutterbuck EA; Balloch A; Marimla RA; Tikkanen L; Lamb KE; Bright KJ; Rabuatoka U; Tikoduadua L; Boelsen LK; Dunne EM; Satzke C; Cheung YB; Pollard AJ; Russell FM; Mulholland EK
J Allergy Clin Immunol; 2016 Jun; 137(6):1772-1779.e11. PubMed ID: 26825000
[TBL] [Abstract][Full Text] [Related]
7. Post hoc analysis of a randomized double-blind trial of the correlation of functional and binding antibody responses elicited by 13-valent and 7-valent pneumococcal conjugate vaccines and association with nasopharyngeal colonization.
Juergens C; Patterson S; Trammel J; Greenberg D; Givon-Lavi N; Cooper D; Gurtman A; Gruber WC; Scott DA; Dagan R
Clin Vaccine Immunol; 2014 Sep; 21(9):1277-81. PubMed ID: 24990907
[TBL] [Abstract][Full Text] [Related]
8. Nasopharyngeal carriage of Streptococcus pneumoniae shortly before vaccination with a pneumococcal conjugate vaccine causes serotype-specific hyporesponsiveness in early infancy.
Dagan R; Givon-Lavi N; Greenberg D; Fritzell B; Siegrist CA
J Infect Dis; 2010 May; 201(10):1570-9. PubMed ID: 20384496
[TBL] [Abstract][Full Text] [Related]
9. Serotype-specific hyporesponsiveness to pneumococcal conjugate vaccine in infants carrying pneumococcus at the time of vaccination.
Väkeväinen M; Soininen A; Lucero M; Nohynek H; Auranen K; Mäkelä PH; Williams G; Käyhty H;
J Pediatr; 2010 Nov; 157(5):778-83.e1. PubMed ID: 20547399
[TBL] [Abstract][Full Text] [Related]
10. Inferior quantitative and qualitative immune responses to pneumococcal conjugate vaccine in infants with nasopharyngeal colonization by Streptococcus pneumoniae during the primary series of immunization.
Madhi SA; Violari A; Klugman KP; Lin G; McIntyre JA; von Gottberg A; Jean-Philippe P; Cotton MF; Adrian P;
Vaccine; 2011 Sep; 29(40):6994-7001. PubMed ID: 21787822
[TBL] [Abstract][Full Text] [Related]
11. Effect of reduced-dose schedules with 7-valent pneumococcal conjugate vaccine on nasopharyngeal pneumococcal carriage in children: a randomized controlled trial.
van Gils EJ; Veenhoven RH; Hak E; Rodenburg GD; Bogaert D; Ijzerman EP; Bruin JP; van Alphen L; Sanders EA
JAMA; 2009 Jul; 302(2):159-67. PubMed ID: 19584345
[TBL] [Abstract][Full Text] [Related]
12. Pneumococcal antibody concentrations and carriage of pneumococci more than 3 years after infant immunization with a pneumococcal conjugate vaccine.
Akinsola AK; Ota MO; Enwere GC; Okoko BJ; Zaman SM; Saaka M; Nsekpong ED; Odutola AA; Greenwood BM; Cutts FT; Adegbola RA
PLoS One; 2012; 7(2):e31050. PubMed ID: 22363544
[TBL] [Abstract][Full Text] [Related]
13. Comparative immunogenicity and efficacy of 13-valent and 7-valent pneumococcal conjugate vaccines in reducing nasopharyngeal colonization: a randomized double-blind trial.
Dagan R; Patterson S; Juergens C; Greenberg D; Givon-Lavi N; Porat N; Gurtman A; Gruber WC; Scott DA
Clin Infect Dis; 2013 Oct; 57(7):952-62. PubMed ID: 23804191
[TBL] [Abstract][Full Text] [Related]
14. Serotype-specific avidity is achieved following a single dose of the 7-valent pneumococcal conjugate vaccine, and is enhanced by 23-valent pneumococcal polysaccharide booster at 12 months.
Russell FM; Balloch A; Licciardi PV; Carapetis JR; Tikoduadua L; Waqatakirewa L; Cheung YB; Mulholland EK; Tang ML
Vaccine; 2011 Jun; 29(27):4499-506. PubMed ID: 21539882
[TBL] [Abstract][Full Text] [Related]
15. Carrier-Induced Hyporesponsiveness to Pneumococcal Conjugate Vaccines: Unraveling the Influence of Serotypes, Timing, and Previous Vaccine Dose.
Dagan R; Jiang Q; Juergens C; Trammel J; Gruber WC; Scott DA
Clin Infect Dis; 2021 Feb; 72(3):448-454. PubMed ID: 31995183
[TBL] [Abstract][Full Text] [Related]
16. Serum IgM antibodies contribute to high levels of opsonophagocytic activities in toddlers immunized with a single dose of the 9-valent pneumococcal conjugate vaccine.
Simell B; Nurkka A; Ekström N; Givon-Lavi N; Käyhty H; Dagan R
Clin Vaccine Immunol; 2012 Oct; 19(10):1618-23. PubMed ID: 22875604
[TBL] [Abstract][Full Text] [Related]
17. Comparison of two-dose priming plus 9-month booster with a standard three-dose priming schedule for a ten-valent pneumococcal conjugate vaccine in Nepalese infants: a randomised, controlled, open-label, non-inferiority trial.
Hamaluba M; Kandasamy R; Upreti SR; Subedi GR; Shrestha S; Bhattarai S; Gurung M; Pradhan R; Voysey M; Gurung S; Pradhan S; Thapa AK; Maharjan R; Kiran U; Kerridge SA; Hinds J; van der Klis F; Snape MD; Murdoch DR; Kelly S; Kelly DF; Adhikari N; Thorson S; Pollard AJ
Lancet Infect Dis; 2015 Apr; 15(4):405-14. PubMed ID: 25701560
[TBL] [Abstract][Full Text] [Related]
18. Immunogenicity and safety of a novel ten-valent pneumococcal conjugate vaccine in healthy infants in The Gambia: a phase 3, randomised, double-blind, non-inferiority trial.
Clarke E; Bashorun A; Adigweme I; Badjie Hydara M; Umesi A; Futa A; Ochoge M; Obayemi D; Edem B; Saidy-Jah E; Onwuchekwa C; Dhere R; Sethna V; Kampmann B; Goldblatt D; Taylor D; Andi-Lolo I; Hosken N; Antony K; Innis BL; Alderson MR; Lamola S
Lancet Infect Dis; 2021 Jun; 21(6):834-846. PubMed ID: 33516293
[TBL] [Abstract][Full Text] [Related]
19. Pneumococcal nasopharyngeal carriage following reduced doses of a 7-valent pneumococcal conjugate vaccine and a 23-valent pneumococcal polysaccharide vaccine booster.
Russell FM; Carapetis JR; Satzke C; Tikoduadua L; Waqatakirewa L; Chandra R; Seduadua A; Oftadeh S; Cheung YB; Gilbert GL; Mulholland EK
Clin Vaccine Immunol; 2010 Dec; 17(12):1970-6. PubMed ID: 20943882
[TBL] [Abstract][Full Text] [Related]
20. Anticapsular serum antibody concentration and protection against pneumococcal colonization among children vaccinated with 7-valent pneumococcal conjugate vaccine.
Millar EV; O'Brien KL; Bronsdon MA; Madore D; Hackell JG; Reid R; Santosham M
Clin Infect Dis; 2007 May; 44(9):1173-9. PubMed ID: 17407035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
